Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy

AIM: To explore the effects of intravitreous injection on vascular endothelial growth inhibitor(VEGI)and its relative cytokines in vitreous and to investigate its role in the pathogenesis of proliferative diabetic retinopathy(PDR). <p>METHODS: Fifty patients with 68 eyes were randomly divided...

Full description

Bibliographic Details
Main Authors:	Rui Shi, Yong Ma, Feng Wang, Jian-Ping Wang
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2015-06-01
Series:	Guoji Yanke Zazhi
Subjects:	proliferative diabetic retinopathy vascular endothelial growth inhibitor vascular endothelial growth factor IL-1β intravitreal injection
Online Access:	http://ies.ijo.cn/cn_publish/2015/6/201506012.pdf

Similar Items

Efficacy and safety of adjuvant intravitreal injection of anti-vascular endothelial growth factors prior to vitrectomy in the treatment of proliferative diabetic retinopathy: A Meta-analysis
by: Jun Li, et al.
Published: (2017-08-01)

Vitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular statusVitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular status
by: Vira S. Ponomarchuk, et al.
Published: (2021-08-01)

Intravitreal injection of Conbercept combined with PPV in the treatment of proliferative diabetic retinopathy
by: Zhou Ou, et al.
Published: (2021-06-01)

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab
by: Jiu-Ke Li, et al.
Published: (2015-12-01)

Morphological and ophthalmoscopic features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy
by: Vira S Ponomarchuk, et al.
Published: (2021-10-01)

Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients—Retrospective Interventional Study
by: Li Chen, et al.
Published: (2021-09-01)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
by: Eugene Yu-Chuan Kang, et al.
Published: (2023-03-01)

Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation
by: Rami Al-Dwairi, et al.
Published: (2023-11-01)

Noninvasive method to reduce vitreous reflux following intravitreal injection
by: Raouf Gaber, et al.
Published: (2023-01-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Study of anti-vascular endothelial growth factor medicine for proliferative diabetic retinopathy at perioperative period
by: Mei Sun, et al.
Published: (2015-10-01)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
by: Lihteh Wu, et al.
Published: (2019-01-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
by: Tyler A. Bahr, et al.
Published: (2023-04-01)

Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01)

Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
by: Zhikun Yang, et al.
Published: (2023-05-01)

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
by: Hui Wang, et al.
Published: (2020-06-01)

Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report
by: Ying Huang, et al.
Published: (2022-03-01)

Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01)

Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use
by: Ramy M. Hanna, et al.
Published: (2020-10-01)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01)

Recent progress in the investigation of VEGF and PEDF of proliferative diabetic retinopathy
by: Xiao-Hong Chen, et al.
Published: (2015-01-01)

Posterior scleritis after biweekly aflibercept intravitreal injections
by: Mélanie Hébert, et al.
Published: (2022-12-01)

Curative effect of 23G micro-invasive vitrectomy combined with intravitreal injection of Ranibizumab in the treatment of proliferative diabetic retinopathy
by: Wei Han, et al.
Published: (2021-03-01)

Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
by: Jun Xu, et al.
Published: (2020-04-01)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018-08-01)

Effect of 25G+pars plana vitrectomy combined with preoperative intravitreal injection of Conbercept on proliferative diabetic retinopathy
by: Jing Xia, et al.
Published: (2023-02-01)

Progress of anti-vascular endothelial growth factor drugs for the treatment of retinopathy of prematurity
by: Tong Ding, et al.
Published: (2023-08-01)

Effects of Topical or Intravitreal Application of Anti-Vascular Endothelial Growth Factor on Density of Intestinal Blood Vessels of Mice
by: Atsushi Ichio, et al.
Published: (2023-04-01)

Curative effect of 25G vitrectomy combined with different anti-VEGF drugs on proliferative diabetic retinopathy
by: Yan-Xia Shang, et al.
Published: (2022-11-01)

Changes in Scleral Thickness Following Repeated Anti-vascular Endothelial Growth Factor Injections
by: Yao Wang, et al.
Published: (2022-05-01)

Effect of anti-vascular endothelial growth factor therapy on intraocular inflammatory cytokine levels in the treatment of proliferative diabetic retinopathy
by: Jin-Xiu Luo, et al.
Published: (2023-05-01)

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
by: Inès Ben Ghezala, et al.
Published: (2022-08-01)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
by: Min Zhao, et al.
Published: (2015-01-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
by: Nada O. Taher, et al.
Published: (2022-05-01)

Effects of Intravitreal Injection of Ranibizumab and Aflibercept on Corneal Endothelium and Central Corneal Thickness
by: Mehmet Coskun
Published: (2018-08-01)

Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy
by: Faruk Nisic, et al.
Published: (2019-03-01)

Correlation of vascular endothelial growth factor and microvascular damage in diabetic retinopathy
by: Ji-Quan Wen, et al.
Published: (2015-12-01)

Managing proliferative diabetic retinopathy in a patient with vitreous hemorrhage: a case report
by: O. B. Koshchynets, et al.
Published: (2022-06-01)